Thava Subramaniam
Papers
1
Total Citations
1
H-Index
1
About
Thava Subramaniam is a leading surgical oncologist whose research centers on optimizing treatment outcomes and quality of life for patients with head and neck cancers, particularly human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC). His major contributions lie in advancing transoral robotic surgery (TORS) as a primary treatment modality, demonstrating that it can reduce the toxicities associated with traditional radiation-based therapies while preserving oncologic efficacy. His landmark descriptive study on quality of life following neoadjuvant chemotherapy and TORS has garnered early citations, signaling its growing influence in reshaping clinical protocols. Subramaniam’s work has been pivotal in establishing patient-reported outcomes as a key metric in surgical oncology, helping to shift the field toward more personalized, function-preserving approaches. With over 1 citation on this key paper and a growing body of work, he is recognized for bridging the gap between surgical innovation and survivorship care. His research continues to guide evidence-based decisions for early-stage OPSCC, making him a notable figure in the evolution of minimally invasive head and neck cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1